SAFETY AND EFFICACY OF NEW ORAL ANTICOAGULANTS IN A COHORT OF 80 VERY OLD PATIENTS AFFECTED WITH ATRIAL FIBRILLATION: A REAL-LIFE MONOCENTRIC EXPERIENCE

被引：0
|
作者：
Forte, V. [1 ]
Buccisano, F. [1 ]
Riccitelli, A. [1 ]
Rossi, V. [1 ]
Del Principe, M. I. [1 ]
Maurillo, L. [1 ]
Di Veroli, A. [1 ]
Ceforo, M. G. [1 ]
De Santis, G. [1 ]
De Bellis, E. [1 ]
Amadori, S. [1 ]
Venditti, A. [1 ]
机构：
[1] Policlin Tor Vergata, Ematol, Rome, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P010
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation
    Baron-Esquivias, Gonzalo
    Fernandez-Aviles, Francisco
    Atienza, Felipe
    Pastor Pueyo, Pablo
    Toro, Rocio
    Sanmartin Fernandez, Marcelo
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (04) : 341 - 353
  • [2] Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation
    Benzimra, Michael
    Bonnamour, Beatrix
    Duracinsky, Martin
    Lalanne, Christophe
    Aubert, Jean-Pierre
    Chassany, Olivier
    Aubin-Auger, Isabelle
    Mahe, Isabelle
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 79 - 87
  • [3] Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
    Russo, Vincenzo
    Rago, Anna
    Proietti, Riccardo
    Di Meo, Federica
    Papa, Andrea Antonio
    Calabro, Paolo
    D'Onofrio, Antonio
    Nigro, Gerardo
    AlTurki, Ahmed
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (02) : 67 - 75
  • [4] Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation
    Schneeweiss, Sebastian
    Gagne, Joshua J.
    Patrick, Amanda R.
    Choudhry, Niteesh K.
    Avorn, Jerry
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 480 - 486
  • [5] The Trends in Utilizing Nonvitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Real-Life Experience
    Avci, Burcak Kilickiran
    Vatan, Bulent
    Tok, Ozge Ozden
    Aidarova, Tamara
    Sahinkus, Salih
    Uygun, Turgut
    Gunduz, Huseyin
    Karakaya, Osman
    Yuksel, Husniye
    Ongen, Zeki
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (08) : 785 - 791
  • [6] The efficacy and safety of new oral anticoagulants in patients with atrial fibrillation in clinical practice
    Moiseev, S. V.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (02) : 220 - 226
  • [7] Dimethylfumarate in Real-Life: Efficacy and Safety in a Monocentric Prospective Cohort of 156 Patients with MS
    Aboab, Jennifer
    Gueguen, Antoine
    Deschamps, Romain
    Bensa, Caroline
    Moulignier, Antoine
    Gout, Olivier
    [J]. NEUROLOGY, 2016, 86
  • [8] Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation
    Lega, Jean-Christophe
    Bertoletti, Laurent
    Gremillet, Cyrielle
    Chapelle, Celine
    Mismetti, Patrick
    Cucherat, Michel
    Vital-Durand, Denis
    Laporte, Silvy
    [J]. PLOS ONE, 2014, 9 (03):
  • [9] EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS: A MONOCENTRIC REAL-LIFE EXPERIENCE
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Sartorelli, Silvia
    Cariddi, Adriana
    Baldissera, Elena
    Dagna, Lorenzo
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1770 - 1771
  • [10] EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS: A MONOCENTRIC REAL-LIFE EXPERIENCE
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Sartorelli, Silvia
    Baldissera, Elena
    Dagna, Lorenzo
    [J]. RHEUMATOLOGY, 2019, 58
12345